Skip to Main Content

Paper Details

Genomic Biomarkers and Genome-Wide Loss-of-Heterozygosity Scores in Metastatic Prostate Cancer Following Progression on Androgen-Targeting Therapies.
JCO Precis Oncol
8
2022
Author NameAffiliation
Emmanuel S AntonarakisUniversity of Minnesota, Masonic Cancer Center
Irene Casanova-SalasVall d'Hebron Institute of Oncology (VHIO) and Vall d'Hebron University Hospital Campus
Jeffrey S RossFoundation Medicine Inc
Jeffrey S RossSUNY Upstate Medical University
Joaquin MateoVall d'Hebron Institute of Oncology (VHIO) and Vall d'Hebron University Hospital Campus
  • 1 - 5

Datasets

Release 1.2